Lisa

Kuan-ju Lin is a Quantitative Pharmacologist at Regeneron, specializing in population PK-PD and safety-efficacy analyses for biologics and small molecules. With extensive experience in regulatory documentation for submissions to the USFDA and EMA, Kuan-ju has developed robust skills in modeling and simulation using tools like NONMEM and Phoenix WinNonlin. Previously, Kuan-ju held positions at Cognigen Corporation, including PK/PD Scientist I and Assistant Director, Pharmacometrics, where they led project teams and consulted on clinical trial design. Kuan-ju earned a Master of Science in Pharmaceutical Sciences from the State University of New York at Buffalo, following a Bachelor of Science in Pharmacy from Taipei Medical University.